Susan S. Smyth, MD, PhD, FACC

Chief, Division of Cardiovascular Medicine
Medical Director, Gill Heart Institute

Practice areas

Practice areas

Clinical interests

  • Acute Coronary Syndromes
  • Antithrombotic Therapy
  • Cardiovascular Disease
  • General Cardiology
  • Ischemic Vascular Disease
  • Platelet and Vascular Biology
  • Thrombosis
  • Translational Cardiovascular Medicine

Susan S. Smyth, MD, PhD, FACC

Chief, Division of Cardiovascular Medicine
Medical Director, Gill Heart Institute

Biography

My name is Susan Smyth; I received my medical degree from University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, N.C. I then completed fellowships at Mt. Sinai Medical School, New York, and University of North Carolina, Chapel Hill, N.C .

I am board certified by the American Board of Internal Medicine in Cardiovascular Disease and a Fellow of the American College of Cardiology.

Faculty rank

Professor of Medicine

Education

Degree
University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill

Residency
University Medical Center, Stony Brook, N.Y.

Fellowship
University of North Carolina at Chapel Hill, Chapel Hill
Mt. Sinai Medical School, New York

Certifications or Special training
American Board of Internal Medicine, Cardiovascular Disease
Fellow of the American College of Cardiology

Women's Heart Health

UK Albert B. Chandler Hospital - Pavilion G
Gill Heart Institute
First Floor, Room G100
1000 S. Limestone
Lexington KY 40536-0602


UK HealthCare accepts many forms of insurance. See list of insurers »

 

Recent Publications

(Five most recent publications from PubMed via an automated list based on the provider’s ID and the University of Kentucky.)
  1. Sexton T, Wallace EL, Smyth SS.
    Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte Interactions.
    Curr Cardiol Rev. 2016 May 3.
  2. Sexton TR, Wallace EL, Chen A, Charnigo RJ, Reda HK, Ziada KM, Gurley JC, Smyth SS.
    Thromboinflammatory response and predictors of outcomes in patients undergoing transcatheter aortic valve replacement.
    J Thromb Thrombolysis. 2016 Apr;41(3):384-93.
  3. Xiang B, Zhang G, Ye S, Zhang R, Huang C, Liu J, Tao M, Ruan C, Smyth SS, Whiteheart SW, Li Z.
    Characterization of a Novel Integrin Binding Protein, VPS33B, Which Is Important for Platelet Activation and In Vivo Thrombosis and Hemostasis.
    Circulation. 2015 Dec 15;132(24):2334-44.
  4. Klyachkin YM, Nagareddy PR, Ye S, Wysoczynski M, Asfour A, Gao E, Sunkara M, Brandon JA, Annabathula R, Ponnapureddy R, Solanki M, Pervaiz ZH, Smyth SS, Ratajczak MZ, Morris AJ, Abdel-Latif A.
    Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute Infarction.
    Stem Cells Transl Med. 2015 Nov;4(11):1333-43.
  5. Beavers CJ, Heron P, Smyth SS, Bain JA, Macaulay TE.
    Obesity and Antiplatelets-Does One Size Fit All?
    Thromb Res. 2015 Oct;136(4):712-6.

View this provider on PubMed